FDAShortage list
FDA drug shortage database — GLP-1 receptor agonist products
Placeholder seed entry recording the source, not an event. Shortage status for approved GLP-1 products materially affects this market: when an approved product is listed as in shortage, compounding of that substance becomes permissible under conditions, and demand shifts toward alternative supply. Resolution of a shortage reverses that. PepIndex records status changes here because they move the whole category.
Source
https://www.accessdata.fda.gov/scripts/drugshortages/The issuing body’s own page is authoritative. PepIndex records what it says and when we recorded it; where the two disagree, the source governs.